Clinical Trial

Comparison of Platelet-rich Plasma and Activated Cytokine-rich Serum Injection Treatments in Patients With Knee Osteoarthritis. (KOA PRP ACS)

Study acronym: KOA PRP ACS
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 19, 2026 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
The effects of single dose injection of platelet rich plasma or conditioned serum in the knee joint in patients with knee osteoarthritis will be compared
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-03-10.
Trial Details
NCT Number NCT07473232
Lead Sponsor Pamukkale University
Conditions Knee Arthritis Osteoarthritis, Platelet Rich Plasma Injection, Conditioned Serum
Enrollment 60 participants
Start Date 2026-04-01
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-03-19